Women & VWD: Periods, Pregnancy & Iron Health
Last updated:
Women with Von Willebrand Disease (VWD) require specialized care for reproductive health. Key management strategies include using hormonal IUDs to reduce heavy menstrual bleeding, monitoring ferritin levels for iron deficiency, and planning factor replacement to allow for safe epidurals and prevent delayed postpartum hemorrhage.
Key Takeaways
- • Hormonal IUDs are highly effective for reducing heavy periods in VWD, while Copper IUDs are generally not recommended due to bleeding risks.
- • Ferritin levels should be monitored to detect iron deficiency fatigue even if hemoglobin appears normal.
- • Epidurals are often possible during labor if factor levels are raised proactively with prophylactic treatment.
- • Women with VWD are at high risk for delayed postpartum hemorrhage due to a rapid drop in factor levels after birth.
- • Tranexamic acid is often prescribed postpartum to prevent late bleeding complications.
For women and girls with Von Willebrand Disease (VWD), managing your reproductive health is one of the most important aspects of your care. Because menstruation and childbirth put a unique demand on your body’s “clotting glue,” having a specialized plan for every life stage is essential [1][2].
Managing Heavy Periods (HMB)
Heavy menstrual bleeding is often the first sign of VWD in women [1]. Finding the right long-term treatment can significantly improve your quality of life [3].
- Hormonal IUDs (Mirena/Liletta): These are considered highly effective for women with VWD [4]. By releasing a small amount of hormone directly in the uterus, they can reduce blood loss by up to 90%, and 60% of users eventually stop having periods entirely (amenorrhea) [5][6].
- The Copper IUD Warning: The Copper IUD (Paragard) is generally not recommended for women with VWD [7]. Because it works by inducing a localized inflammatory response, it often increases menstrual blood loss, which can be dangerous or overwhelming if you already have a bleeding disorder [7].
- Iron & Ferritin: Chronic bleeding drains your iron stores. Even if your hemoglobin (the oxygen-carrier in your blood) looks normal, your ferritin (iron storage) may be dangerously low [8][9]. Low ferritin can cause extreme fatigue and brain fog, so regular monitoring is vital [10][2].
Pregnancy & Labor: Planning for an Epidural
Pregnancy naturally raises VWF levels in many women, but this rise is temporary [11][12].
- Epidural Access: Many women with VWD worry that they cannot have an epidural (neuraxial anesthesia) [13]. This is not true for most. By using prophylactic treatment (like DDAVP or factor concentrates) to raise your VWF activity levels above 50 IU/dL, your care team can create a “safe window” for the anesthesia to be administered [13][14][15].
- The 3rd Trimester Check: Your hematologist will check your factor levels around week 34–36 to decide if you need a “booster” of factor before labor begins [13][11].
The “Postpartum Crash” & Delayed Bleeding
After birth, your factor levels drop rapidly back to your baseline. This “postpartum crash” puts you at high risk for delayed (secondary) postpartum hemorrhage, which can happen anywhere from 2 to 19 days after delivery [12][16].
Signs of Delayed PPH (Watch for these after going home):
- Soaking through a pad in less than one hour after your initial bleeding (lochia) has already slowed down [12][9].
- Passing new, large blood clots (larger than a quarter) [12][16].
- Feeling suddenly lightheaded, dizzy, or short of breath [17].
To prevent this, your doctor may prescribe tranexamic acid or additional factor infusions for several days after you leave the hospital [12][18].
Planning for Puberty: For parents of girls with VWD, it is important to have a plan in place before her first period. Early consultation with a hematologist can ensure she has access to TXA or other treatments from day one, preventing the trauma and health risks of severe initial bleeding [4].
By building a “multidisciplinary team”—including a hematologist, your OB/GYN, and your anesthesiologist—you can navigate pregnancy and childbirth with confidence and safety. [14][13]
Frequently Asked Questions
Can I have an epidural during labor if I have VWD?
Is the Copper IUD safe for women with Von Willebrand Disease?
Why do I feel tired even if my hemoglobin is normal?
What is the 'postpartum crash' in VWD factor levels?
What are the signs of delayed postpartum hemorrhage I should watch for?
Questions for Your Doctor
- • If I choose a hormonal IUD (like Mirena), how quickly can I expect my periods to lighten?
- • Should we check my ferritin levels even if my hemoglobin is normal, and what ferritin number should we target for me?
- • What is our exact plan to raise my VWF levels so that I am eligible for an epidural (neuraxial anesthesia)?
- • How many days after birth should I continue my VWF replacement therapy or tranexamic acid to prevent delayed hemorrhage?
- • If I soak a pad in less than an hour after returning home from the hospital, what is the 'emergency line' I should call?
Questions for You
- • Are you currently taking iron supplements, and do you know if your ferritin levels have been checked recently? Iron deficiency can affect your energy and overall health.
- • If you have been using hormonal treatments (like the pill) for your periods, have they been effective, or are you still experiencing 'breakthrough' heavy bleeding?
- • Do you have a clear birth plan that includes how your care team will handle the 'postpartum crash' in factor levels after delivery?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Gynecological bleeding in women with congenital bleeding disorders: A comprehensive cohort from Iran.
Zafarani A, Ghodratnia E, Amirzargar MR, et al.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2024; (63(4)):103941 doi:10.1016/j.transci.2024.103941.
PMID: 38735129 - 2
Von Willebrand disease: classification and epidemiology.
Castaman G, Bramante Federici A
Haematologica 2026; (111(1)):26-34 doi:10.3324/haematol.2024.286058.
PMID: 41496701 - 3
Patient-reported outcomes in autosomal inherited bleeding disorders: A systematic literature review.
van Hoorn ES, Houwing ME, Al Arashi W, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2022; (28(2)):197-214 doi:10.1111/hae.14492.
PMID: 35040234 - 4
Diagnosis and Management of Heavy Menstrual Bleeding and Bleeding Disorders in Adolescents.
Borzutzky C, Jaffray J
JAMA pediatrics 2020; (174(2)):186-194 doi:10.1001/jamapediatrics.2019.5040.
PMID: 31886837 - 5
Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.
Oliveira JA, Eskandar K, Chagas J, et al.
Contraception 2024; (135()):110450 doi:10.1016/j.contraception.2024.110450.
PMID: 38614274 - 6
Management of heavy menstrual bleeding in women with bleeding disorders in a tertiary care center.
Kuthiala S, Grabell J, Relke N, et al.
Research and practice in thrombosis and haemostasis 2023; (7(3)):100119 doi:10.1016/j.rpth.2023.100119.
PMID: 37065843 - 7
Heavy Menstrual Bleeding and Hormonal Therapy in Women with Type 1 von Willebrand Disease Enrolled on the Zimmerman Program.
Machin N, Navarrete A, Rothenberger S, et al.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2025; (31()):10760296251359294 doi:10.1177/10760296251359294.
PMID: 40660798 - 8
Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease-a cohort study.
Myrin-Westesson L, Elfvinge P, Zetterberg E, Olsson A
Research and practice in thrombosis and haemostasis 2025; (9(4)):102949 doi:10.1016/j.rpth.2025.102949.
PMID: 40697484 - 9
Significant gynecological bleeding in women with low von Willebrand factor levels.
Lavin M, Aguila S, Dalton N, et al.
Blood advances 2018; (2(14)):1784-1791 doi:10.1182/bloodadvances.2018017418.
PMID: 30042144 - 10
What have we learned about the patient's experience of von Willebrand disease? A focus on women.
VanderMeulen H, Arya S, Nersesian S, et al.
Hematology. American Society of Hematology. Education Program 2022; (2022(1)):631-636 doi:10.1182/hematology.2022000391.
PMID: 36485077 - 11
The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy.
Delbrück C, Miesbach W
Acta haematologica 2019; (142(2)):71-78 doi:10.1159/000496820.
PMID: 31085919 - 12
Pregnancy and delivery in women with von Willebrand disease.
Castaman G, James PD
European journal of haematology 2019; (103(2)):73-79 doi:10.1111/ejh.13250.
PMID: 31107984 - 13
Examining international practices in the management of pregnant women with von Willebrand disease.
Lavin M, Sánchez Luceros A, Kouides P, et al.
Journal of thrombosis and haemostasis : JTH 2022; (20(1)):82-91 doi:10.1111/jth.15561.
PMID: 34661341 - 14
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
Connell NT, Flood VH, Brignardello-Petersen R, et al.
Blood advances 2021; (5(1)):301-325 doi:10.1182/bloodadvances.2020003264.
PMID: 33570647 - 15
Recombinant von Willebrand factor use in obstetric anesthesia.
Sharpe EE, Pompeian RJ, Marshall AL
Proceedings (Baylor University. Medical Center) 2025; (38(2)):142-147 doi:10.1080/08998280.2024.2430141.
PMID: 39990009 - 16
Postpartum Hemorrhage in Patients with Type 1 von Willebrand Disease: A Systematic Review.
Pierce-Williams RAM, Makhamreh MM, Blakey-Cheung S, et al.
Seminars in thrombosis and hemostasis 2022; (48(2)):219-228 doi:10.1055/s-0041-1736572.
PMID: 34749402 - 17
Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.
Mason JA, Robertson JD, McCosker J, et al.
Haemophilia : the official journal of the World Federation of Hemophilia 2016; (22(5)):700-5 doi:10.1111/hae.12949.
PMID: 27385253 - 18
Von Willebrand Disease and Pregnancy: Management Protocol From Labor to the Postpartum Period.
Muñoz Vargas BA, Contreras Valero SJ, Aragon Mendoza RL, et al.
Cureus 2024; (16(2)):e53465 doi:10.7759/cureus.53465.
PMID: 38435184
This guide covers reproductive health for women with VWD for educational purposes. Always coordinate your pregnancy and treatment plans with your hematologist and OB/GYN.
Stay up to date
Get notified when new research about Von Willebrand Disease is published.
No spam. Unsubscribe anytime.